Neural stem cell transplantation at critical period improves learning and memory through restoring synaptic impairment in Alzheimer’s disease mouse model
Open Access
- 18 June 2015
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 6 (6) , e1789
Abstract
Alzheimer’s disease (AD) is characterized by neuronal loss in several regions of the brain. Recent studies have suggested that stem cell transplantation could serve as a potential therapeutic strategy to halt or ameliorate the inexorable disease progression. However, the optimal stage of the disease for stem cell transplantation to have a therapeutic effect has yet to be determined. Here, we demonstrated that transplantation of neural stem cells into 12-month-old Tg2576 brains markedly improved both cognitive impairments and neuropathological features by reducing β-amyloid processing and upregulating clearance of β-amyloid, secretion of anti-inflammatory cytokines, endogenous neurogenesis, as well as synapse formation. In contrast, the stem cell transplantation did not recover cognitive dysfunction and β-amyloid neuropathology in Tg2576 mice aged 15 months when the memory loss is manifest. Overall, this study underscores that stem cell therapy at optimal time frame is crucial to obtain maximal therapeutic effects that can restore functional deficits or stop the progression of AD.Keywords
This publication has 48 references indexed in Scilit:
- Targeting Astrocytes Ameliorates Neurologic Changes in a Mouse Model of Alzheimer's DiseaseThe Journal of Neuroscience, 2012
- The Preventive and Therapeutic Effects of Intravenous Human Adipose-Derived Stem Cells in Alzheimer’s Disease MicePLOS ONE, 2012
- S100a9 Knockdown Decreases the Memory Impairment and the Neuropathology in Tg2576 Mice, AD Animal ModelPLOS ONE, 2010
- Immune Influence on Adult Neural Stem Cell Regulation and FunctionNeuron, 2009
- Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer diseaseProceedings of the National Academy of Sciences, 2009
- Bone marrow-derived mesenchymal stem cells reduce brain amyloid-β deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse modelNeuroscience Letters, 2009
- Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease MiceThe Journal of Neuroscience, 2008
- BDNF improves the effects of neural stem cells on the rat model of Alzheimer's disease with unilateral lesion of fimbria-fornixNeuroscience Letters, 2008
- Spatial Relational Memory Requires Hippocampal Adult NeurogenesisPLOS ONE, 2008
- Neural stem cells transplantation in cortex in a mouse model of Alzheimer’s diseaseThe Journal of Medical Investigation, 2006